Crescent Diagnostics, Ltd. News - Profile and Newsroom at Send2Press Newswire

Crescent Diagnostics, Ltd. Newsroom - Profile and News Archive

Crescent Diagnostics, Ltd. | new test for bone health, Crescent Diagnostics, Ltd., Seroba BioVentures Limited:, biomarker, Bone Quality Test, BQT, patient, expensive x-ray based DEXA scans, predictor of fracture risk, biotech, Raman spectrometry, Dr. Towler, Ernest Poku, Alan O'Connell, monitoring bone health, London, U.K., bio ventures

Engage with Crescent Diagnostics, Ltd.

Follow:

Press Releases from Crescent Diagnostics, Ltd. :

Crescent Diagnostics Secures Venture Capital Financing Investment to Advance the Development of its Novel Bone Quality Test

Jun 13, 2006 3:28 PM EST

LONDON, UK – June 13 (SEND2PRESS NEWSWIRE) — Crescent Diagnostics Ltd. (Crescent), a privately held company developing a new test for bone health, today announced the completion of a GBP 550,000 (Euros 800,000) funding round. Seroba BioVentures (Seroba), a Dublin-based specialist life science venture capital firm led the round in conjunction with a number of private investors.